After over a decade with HIV, a Norwegian man received a surprise through a stem cell donation from his sibling. The gifted ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released "Still Here," a social media video campaign designed to spark crucial ...

Deploying lenacapavir will require rethinking who delivers HIV prevention, how it is financed, and what policy infrastructure ...

A man with HIV entered long-term remission after receiving HIV-resistant stem cells through a bone marrow transplant to treat ...

Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to ...

Data collected by the State Department that has not previously been made public indicates that the number of people receiving ...

"We haven't quite made it to the promised land. We're getting close." ...

U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in ...

A groundbreaking instance of sustained HIV remission post-stem cell transplant is transforming our understanding of the virus ...

Footage shows staff in Pakistan injecting without gloves and reusing syringes, but the hospital boss refuses to acknowledge ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

The patient's brother unknowingly carried a homozygous mutation that inhibits HIV infections, leading to what doctors call ...